The scientific rationale for the investment is straightforward. Radiation therapy remains a cornerstone of modern cancer treatment, with more than half of all patients receiving radiation at some point during their care, across virtually all cancer types and stages. Yet in many academic health centers, radiation oncology has historically operated as a clinical service rather than a fully integrated academic department with its own research enterprise, trial portfolio, and training mission. By elevating the discipline to departmental status, LSU Health New Orleans intends to build upon its existing clinical services with a structure dedicated to advancing research, developing clinical trials, recruiting faculty, and educating the next generation of physicians. That structural change matters, because the departments that drive discovery in oncology are typically those that combine bedside expertise with laboratory investigation and formal teaching responsibilities.

The new department is also designed to strengthen collaboration among radiation oncologists, medical oncologists, surgeons, scientists, and other specialists working to develop more precise and effective treatments. This multidisciplinary infrastructure is considered an essential component of the LSU LCMC Health Cancer Center’s strategy to build a comprehensive cancer program capable of meeting the rigorous standards required for NCI designation. NCI-designated centers must demonstrate depth in basic, translational, and clinical research, robust clinical trial activity, and coordinated multidisciplinary care, and a strong academic radiation oncology department touches each of those requirements. For patients in Louisiana, a state that carries a disproportionate cancer burden, the practical promise is broader access to advanced radiotherapy techniques and to clinical trials that combine radiation with immunotherapy and other targeted systemic therapies.

As chair of the new department, Dr. Iyengar will lead the development of an academic program that integrates patient care, education, and research. His mandate includes recruiting faculty, expanding multidisciplinary cancer programs, developing innovative clinical trials, mentoring medical students and physicians in training, and fostering collaborations that move scientific discoveries from the bench into new treatment options for patients. He will also practice at University Medical Center New Orleans, the region’s only Level 1 Trauma Center and Burn Center, where he brings particular expertise in thoracic cancers, metastatic disease, and advanced radiation therapies. His clinical focus will include lung cancer and other thoracic malignancies, as well as complex cancers requiring highly specialized treatment, with an emphasis on strategies that pair radiation with immunotherapy and molecularly targeted agents.

Dr. Iyengar arrives from Memorial Sloan Kettering Cancer Center, one of the nation’s oldest and most distinguished NCI-designated comprehensive cancer centers, where he served as director of the Metastatic Service in the Department of Radiation Oncology. He is widely regarded as a leader in thoracic radiation oncology whose work has helped advance the treatment of lung cancer and metastatic disease. A central theme of his research career is oligometastatic disease, a condition in which a patient’s cancer has spread to only a limited number of sites. For decades, metastatic cancer was treated almost exclusively with systemic therapies, but the oligometastatic state has emerged as a distinct biological and clinical entity in which localized treatments such as high-precision radiation can potentially alter the disease trajectory. Through clinical trials, translational research, and contributions to national treatment guidelines, Dr. Iyengar has helped define how ablative radiation can be deployed in this setting, contributing to evolving standards of care for patients with advanced lung cancer and limited metastatic disease.

His broader research portfolio spans precision radiation therapy, lung cancer, oligometastatic disease, cancer metabolism, and novel combinations of radiation with systemic therapies designed to improve patient outcomes. That scientific range is reflected in his national leadership roles. He serves on the National Cancer Institute’s Thoracic Malignancy Steering Committee, holds the position of Translational Vice Chair of the NCI NRG Lung Committee, and chairs international guideline committees. He has authored hundreds of peer-reviewed publications advancing the field of radiation oncology. Before joining Memorial Sloan Kettering, he held several senior leadership positions at UT Southwestern Medical Center, including vice chair for strategic initiatives, associate vice chair for clinical research, and director of clinical research in the Department of Radiation Oncology. He earned his medical and doctoral degrees from Albert Einstein College of Medicine and completed his radiation oncology residency at The University of Texas MD Anderson Cancer Center, an academic lineage that spans several of the country’s most influential cancer institutions.

In addition to chairing the department, Dr. Iyengar has been named Associate Director for Intercampus Research for the LSU LCMC Health Cancer Center. In that capacity he will oversee the creation of a statewide digital early phase clinical trial network platform intended to integrate and connect cancer physicians and patients across Louisiana. Early phase trials, which test the safety and initial efficacy of new agents and treatment combinations, are often concentrated at large academic centers in major metropolitan areas, leaving patients elsewhere with limited access. A digital network that links community oncologists and academic investigators could widen the funnel of trial participation statewide, a critical step for a center seeking NCI designation, which requires demonstrated accrual to clinical trials across a catchment area. Dr. Iyengar will also convene a transdisciplinary group of researchers drawn from the LSU LCMC Health Cancer Center, Pennington Biomedical Research Center, and LSU Health Shreveport to investigate how metabolic health and nutrition influence cancer care and outcomes, an emerging frontier that connects obesity biology, systemic metabolism, and treatment response.

Institutional leaders framed the recruitment as a generational investment. Dr. David Guzick, Senior Vice Chancellor of LSU Health New Orleans, described establishing the first academic Department of Radiation Oncology as a major investment in the future of the institution and the health of the state, noting that Dr. Iyengar brings the experience, vision, and scientific leadership needed to build an exceptional department, educate tomorrow’s physicians, and expand access to highly specialized cancer care. Dr. Lucio Miele, director of the LSU LCMC Health Cancer Center, said that leading cancer centers are built by recruiting exceptional people who elevate every part of the mission, from patient care and research to education and innovation, and characterized Dr. Iyengar as one of the foremost leaders in radiation oncology whose decision to join reflects the momentum the center is building. Tom Patrias, CEO of University Medical Center New Orleans, emphasized that bringing a nationally recognized radiation oncologist to the hospital is a significant step forward for cancer care in the region, expanding the specialized treatments and clinical research available to patients in Louisiana.

For Dr. Iyengar himself, the appeal lies in the opportunity to build. He described his career as having been spent at institutions committed to advancing cancer care through research, innovation, and collaboration, and said that what attracted him to LSU Health New Orleans was the chance to create something with the potential to make a lasting difference. Establishing a new academic Department of Radiation Oncology while expanding access to advanced treatments and clinical research, he noted, is a once-in-a-career opportunity, one that he believes can change the future trajectory of cancer care in Louisiana, train the next generation of physician-scientists, and bring more promising discoveries to patients throughout the region. The recruitment also signals LSU Health New Orleans’ broader strategy of attracting nationally recognized physician-scientists whose expertise expands access to advanced cancer care, accelerates scientific discovery, and strengthens the state’s academic medical workforce, an effort with implications that extend well beyond a single department to the entire landscape of cancer treatment in the Gulf South.

Subject of Research: Establishment of the first academic Department of Radiation Oncology at LSU Health New Orleans under Dr. Puneeth Iyengar

Article Title: LSU Health New Orleans recruits internationally recognized leader to establish institution’s first academic department of radiation oncology

Article References: LSU Health New Orleans recruits internationally recognized leader to establish institution’s first academic department of radiation oncology. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: radiation oncology, LSU Health New Orleans, cancer center, NCI designation, Puneeth Iyengar, lung cancer, oligometastatic disease, clinical trials, immunotherapy, thoracic malignancies, cancer metabolism, physician training